Putting the award page together from the records…
Putting the award page together from the records…
NIAID COVID-19 ACTIV3
Up for re-bid: ends 2027-02-28. Recompete brief → · NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM ↗
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
5 actions since 2024-05-30. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-09 | P00011 | Administrative change | -$74.47M | NIAID COVID-19 ACTIV3 |
| 2026-03-26 | P00010 | Administrative change | -$1.08M | NIAID COVID-19 ACTIV3 |
| 2025-06-13 | P00009 | Administrative change | $2.00M | NIAID COVID-19 ACTIV3 |
| 2025-04-24 | P00008 | Terminated for convenience | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| 2024-05-30 | P00007 | Administrative change | $0 | NIAID COVID-19 ACTIV3 |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗